T-ALL cells (Jurkat cells) treated with homoharringtonine
Homoharringtonine (HHT) is a plant alkaloid approved by the FDA for treating chronic myeloid leukemia (CML). This study aims to investigate whether HHT could inhibit cell proliferation and growth in T-cell acute lymphoblastic leukemia (T-ALL cells).